Christian Lattermann, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cartilage, Articular | 29 | 2023 | 1095 | 4.560 |
Why?
|
| Knee Injuries | 27 | 2021 | 490 | 3.160 |
Why?
|
| Patellofemoral Joint | 9 | 2021 | 124 | 3.160 |
Why?
|
| Knee Joint | 32 | 2023 | 1680 | 2.880 |
Why?
|
| Chondrocytes | 10 | 2023 | 804 | 2.260 |
Why?
|
| Ligaments, Articular | 6 | 2019 | 298 | 1.910 |
Why?
|
| Joint Instability | 13 | 2020 | 792 | 1.850 |
Why?
|
| Osteoarthritis | 10 | 2023 | 1036 | 1.750 |
Why?
|
| Osteoarthritis, Knee | 11 | 2021 | 1222 | 1.710 |
Why?
|
| Menisci, Tibial | 9 | 2022 | 269 | 1.630 |
Why?
|
| Patellar Dislocation | 4 | 2017 | 64 | 1.490 |
Why?
|
| Arthroscopy | 15 | 2021 | 926 | 1.470 |
Why?
|
| Orthopedic Procedures | 12 | 2018 | 1288 | 1.340 |
Why?
|
| Patellar Ligament | 3 | 2017 | 60 | 1.270 |
Why?
|
| Arthralgia | 3 | 2018 | 456 | 1.180 |
Why?
|
| Cartilage Diseases | 5 | 2021 | 160 | 1.120 |
Why?
|
| Tendons | 7 | 2019 | 548 | 1.050 |
Why?
|
| Intra-Articular Fractures | 2 | 2022 | 68 | 1.020 |
Why?
|
| Synovial Fluid | 4 | 2022 | 394 | 0.960 |
Why?
|
| Collagen Type II | 4 | 2022 | 151 | 0.870 |
Why?
|
| Chondrogenesis | 3 | 2020 | 247 | 0.860 |
Why?
|
| Bone Transplantation | 4 | 2022 | 907 | 0.850 |
Why?
|
| Patella | 8 | 2020 | 320 | 0.840 |
Why?
|
| Gene Transfer Techniques | 7 | 2006 | 1224 | 0.720 |
Why?
|
| Cartilage | 3 | 2021 | 818 | 0.710 |
Why?
|
| Stifle | 1 | 2018 | 28 | 0.680 |
Why?
|
| Running | 2 | 2013 | 480 | 0.610 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2012 | 849 | 0.610 |
Why?
|
| Hip Joint | 4 | 2011 | 1002 | 0.610 |
Why?
|
| Musculoskeletal System | 2 | 2009 | 175 | 0.570 |
Why?
|
| Soccer | 3 | 2020 | 133 | 0.550 |
Why?
|
| Collagen Type I | 2 | 2018 | 592 | 0.530 |
Why?
|
| Inflammation | 7 | 2023 | 10638 | 0.530 |
Why?
|
| Patellofemoral Pain Syndrome | 2 | 2011 | 15 | 0.520 |
Why?
|
| Femur | 7 | 2020 | 1297 | 0.510 |
Why?
|
| Arthroplasty | 2 | 2017 | 305 | 0.480 |
Why?
|
| Glycoproteins | 2 | 2012 | 2263 | 0.470 |
Why?
|
| Fracture Healing | 5 | 2004 | 427 | 0.460 |
Why?
|
| Anterior Cruciate Ligament | 12 | 2018 | 415 | 0.440 |
Why?
|
| Musculoskeletal Diseases | 3 | 2019 | 581 | 0.430 |
Why?
|
| Gait | 2 | 2020 | 793 | 0.430 |
Why?
|
| Tibia | 3 | 2021 | 1077 | 0.420 |
Why?
|
| Rotator Cuff | 2 | 2011 | 326 | 0.400 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 2282 | 0.400 |
Why?
|
| Debridement | 2 | 2011 | 492 | 0.390 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2021 | 1790 | 0.380 |
Why?
|
| Walking | 2 | 2020 | 1180 | 0.380 |
Why?
|
| Transplantation, Autologous | 6 | 2023 | 2124 | 0.380 |
Why?
|
| Tennis Elbow | 1 | 2010 | 18 | 0.380 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2009 | 1018 | 0.370 |
Why?
|
| Tendon Injuries | 2 | 2011 | 313 | 0.370 |
Why?
|
| Injections, Intra-Articular | 4 | 2021 | 278 | 0.370 |
Why?
|
| Transplantation, Homologous | 7 | 2022 | 4776 | 0.360 |
Why?
|
| Humans | 108 | 2023 | 744343 | 0.350 |
Why?
|
| Exercise Therapy | 2 | 2014 | 906 | 0.350 |
Why?
|
| Rehabilitation | 1 | 2011 | 134 | 0.350 |
Why?
|
| Sickness Impact Profile | 1 | 2011 | 302 | 0.350 |
Why?
|
| Activities of Daily Living | 2 | 2021 | 2418 | 0.350 |
Why?
|
| Radiography | 9 | 2021 | 7023 | 0.350 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2107 | 0.340 |
Why?
|
| Peptide Fragments | 2 | 2020 | 5097 | 0.340 |
Why?
|
| Tendinopathy | 1 | 2011 | 154 | 0.340 |
Why?
|
| Foot | 1 | 2011 | 527 | 0.310 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 1855 | 0.300 |
Why?
|
| Management Information Systems | 1 | 2007 | 50 | 0.290 |
Why?
|
| Young Adult | 18 | 2023 | 56430 | 0.280 |
Why?
|
| Muscle Weakness | 2 | 2021 | 413 | 0.270 |
Why?
|
| Peptides | 1 | 2018 | 4409 | 0.270 |
Why?
|
| Foot Injuries | 1 | 2007 | 148 | 0.260 |
Why?
|
| Adenoviridae | 8 | 2006 | 1099 | 0.260 |
Why?
|
| Fluoroscopy | 2 | 2007 | 924 | 0.250 |
Why?
|
| Quadriceps Muscle | 3 | 2021 | 144 | 0.240 |
Why?
|
| Muscle Strength | 3 | 2021 | 592 | 0.230 |
Why?
|
| Pain | 5 | 2022 | 4986 | 0.230 |
Why?
|
| Genetic Vectors | 7 | 2006 | 3420 | 0.230 |
Why?
|
| Range of Motion, Articular | 4 | 2015 | 1578 | 0.230 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 1439 | 0.230 |
Why?
|
| Fractures, Bone | 3 | 2007 | 1947 | 0.230 |
Why?
|
| Athletic Injuries | 2 | 2010 | 1154 | 0.210 |
Why?
|
| Pain Measurement | 4 | 2021 | 3420 | 0.210 |
Why?
|
| Physical Therapy Modalities | 2 | 2016 | 550 | 0.210 |
Why?
|
| Osteotomy | 4 | 2021 | 822 | 0.210 |
Why?
|
| Regeneration | 3 | 2020 | 1485 | 0.210 |
Why?
|
| Lower Extremity | 1 | 2010 | 1158 | 0.210 |
Why?
|
| Female | 44 | 2023 | 380194 | 0.200 |
Why?
|
| Muscle, Skeletal | 4 | 2019 | 4931 | 0.200 |
Why?
|
| Rotation | 1 | 2023 | 523 | 0.200 |
Why?
|
| Synovitis | 3 | 2020 | 209 | 0.200 |
Why?
|
| Adult | 33 | 2023 | 214055 | 0.200 |
Why?
|
| Tissue Preservation | 2 | 2020 | 182 | 0.200 |
Why?
|
| Male | 38 | 2023 | 350118 | 0.190 |
Why?
|
| Cytokines | 5 | 2020 | 7322 | 0.190 |
Why?
|
| Graft Survival | 2 | 2022 | 3737 | 0.190 |
Why?
|
| Inflammation Mediators | 2 | 2023 | 1889 | 0.190 |
Why?
|
| Treatment Outcome | 18 | 2021 | 63114 | 0.180 |
Why?
|
| Bone Morphogenetic Proteins | 6 | 2006 | 838 | 0.180 |
Why?
|
| Quality of Life | 6 | 2023 | 12804 | 0.180 |
Why?
|
| Hemarthrosis | 1 | 2020 | 38 | 0.180 |
Why?
|
| Dependovirus | 1 | 2005 | 706 | 0.180 |
Why?
|
| Adolescent | 16 | 2023 | 85781 | 0.170 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2022 | 369 | 0.170 |
Why?
|
| Dental Pulp | 1 | 2020 | 82 | 0.170 |
Why?
|
| Indazoles | 1 | 2021 | 289 | 0.170 |
Why?
|
| Viscosupplements | 1 | 2018 | 23 | 0.170 |
Why?
|
| Bone Screws | 5 | 2009 | 520 | 0.170 |
Why?
|
| Betamethasone | 1 | 2018 | 45 | 0.170 |
Why?
|
| Hyaluronic Acid | 2 | 2021 | 491 | 0.170 |
Why?
|
| Tendon Transfer | 4 | 2011 | 122 | 0.170 |
Why?
|
| Kentucky | 2 | 2016 | 83 | 0.160 |
Why?
|
| Triamcinolone Acetonide | 1 | 2018 | 101 | 0.160 |
Why?
|
| Growth Substances | 1 | 2000 | 784 | 0.160 |
Why?
|
| Horses | 1 | 2018 | 304 | 0.160 |
Why?
|
| Rabbits | 8 | 2006 | 4894 | 0.150 |
Why?
|
| Wound Healing | 4 | 2010 | 2785 | 0.150 |
Why?
|
| Tissue Engineering | 3 | 2020 | 1880 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 5 | 2006 | 2007 | 0.150 |
Why?
|
| Tennessee | 1 | 2016 | 117 | 0.140 |
Why?
|
| Recurrence | 4 | 2012 | 8340 | 0.140 |
Why?
|
| Cattle | 1 | 2022 | 3922 | 0.140 |
Why?
|
| Cadaver | 2 | 2019 | 1337 | 0.140 |
Why?
|
| Postoperative Complications | 6 | 2021 | 15295 | 0.140 |
Why?
|
| Follow-Up Studies | 10 | 2022 | 39050 | 0.140 |
Why?
|
| Joint Diseases | 1 | 2021 | 480 | 0.140 |
Why?
|
| Catastrophization | 1 | 2019 | 316 | 0.140 |
Why?
|
| Task Performance and Analysis | 1 | 2020 | 780 | 0.140 |
Why?
|
| Bone Remodeling | 1 | 2020 | 575 | 0.140 |
Why?
|
| Obesity | 1 | 2018 | 12745 | 0.130 |
Why?
|
| Osteochondritis Dissecans | 1 | 2017 | 111 | 0.130 |
Why?
|
| Arthroscopes | 3 | 2007 | 11 | 0.130 |
Why?
|
| Electric Stimulation Therapy | 1 | 2021 | 605 | 0.130 |
Why?
|
| Sports Medicine | 1 | 2017 | 225 | 0.120 |
Why?
|
| Tissue Transplantation | 1 | 2015 | 130 | 0.120 |
Why?
|
| Imidazoles | 1 | 2021 | 1206 | 0.120 |
Why?
|
| Serial Publications | 1 | 2014 | 10 | 0.120 |
Why?
|
| Interleukin-6 | 2 | 2022 | 3200 | 0.120 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2014 | 134 | 0.120 |
Why?
|
| Transduction, Genetic | 3 | 2005 | 913 | 0.110 |
Why?
|
| Posterior Cruciate Ligament | 2 | 2009 | 88 | 0.110 |
Why?
|
| Animals | 18 | 2022 | 168757 | 0.110 |
Why?
|
| Movement | 1 | 2020 | 1471 | 0.110 |
Why?
|
| Ontario | 1 | 2014 | 383 | 0.110 |
Why?
|
| Absorbable Implants | 2 | 2009 | 342 | 0.110 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2020 | 1632 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2017 | 1184 | 0.100 |
Why?
|
| Connective Tissue | 1 | 1994 | 420 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 8949 | 0.100 |
Why?
|
| Bone Diseases, Developmental | 1 | 2012 | 130 | 0.100 |
Why?
|
| Tenodesis | 1 | 2011 | 49 | 0.100 |
Why?
|
| Observer Variation | 1 | 2017 | 2593 | 0.100 |
Why?
|
| Weight-Bearing | 1 | 2013 | 515 | 0.090 |
Why?
|
| Comorbidity | 2 | 2018 | 10388 | 0.090 |
Why?
|
| Joints | 1 | 2012 | 326 | 0.090 |
Why?
|
| Shoulder Pain | 1 | 2011 | 144 | 0.090 |
Why?
|
| Leg | 2 | 2021 | 1116 | 0.090 |
Why?
|
| Clinical Protocols | 1 | 2016 | 1462 | 0.090 |
Why?
|
| Osteoblasts | 2 | 2005 | 1166 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2019 | 8324 | 0.090 |
Why?
|
| Biological Products | 1 | 2019 | 860 | 0.090 |
Why?
|
| Medical Illustration | 1 | 2010 | 133 | 0.090 |
Why?
|
| Rupture | 4 | 2018 | 433 | 0.090 |
Why?
|
| Pyridines | 1 | 2021 | 2825 | 0.080 |
Why?
|
| Muscle Contraction | 2 | 2010 | 1240 | 0.080 |
Why?
|
| Isometric Contraction | 1 | 2009 | 143 | 0.080 |
Why?
|
| Disease Progression | 2 | 2018 | 13284 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 6489 | 0.080 |
Why?
|
| Weight Lifting | 1 | 2009 | 131 | 0.080 |
Why?
|
| Disability Evaluation | 2 | 2018 | 1827 | 0.080 |
Why?
|
| Proteome | 1 | 2018 | 1799 | 0.080 |
Why?
|
| Electromyography | 2 | 2010 | 1379 | 0.080 |
Why?
|
| Physical Examination | 2 | 2011 | 1237 | 0.080 |
Why?
|
| Medical History Taking | 1 | 2011 | 783 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 6038 | 0.080 |
Why?
|
| Stem Cells | 2 | 2020 | 3567 | 0.070 |
Why?
|
| Cohort Studies | 4 | 2023 | 40561 | 0.070 |
Why?
|
| Surgical Flaps | 1 | 1996 | 1640 | 0.070 |
Why?
|
| Middle Aged | 15 | 2021 | 213383 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1676 | 0.070 |
Why?
|
| Prospective Studies | 6 | 2019 | 53288 | 0.070 |
Why?
|
| Femoral Fractures | 2 | 2000 | 376 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 2 | 5 | 2006 | 350 | 0.060 |
Why?
|
| Reoperation | 4 | 2023 | 4201 | 0.060 |
Why?
|
| Macrophages | 1 | 2020 | 5655 | 0.060 |
Why?
|
| Intraoperative Care | 1 | 2009 | 767 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2014 | 4217 | 0.060 |
Why?
|
| Immunocompetence | 1 | 2005 | 137 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 1741 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2004 | 5078 | 0.060 |
Why?
|
| Research Design | 2 | 2019 | 5987 | 0.060 |
Why?
|
| Transgenes | 2 | 2005 | 1009 | 0.060 |
Why?
|
| Disease Transmission, Infectious | 1 | 2009 | 547 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 35421 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2023 | 77449 | 0.060 |
Why?
|
| Fractures, Ununited | 1 | 2004 | 165 | 0.050 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 2576 | 0.050 |
Why?
|
| Hip | 2 | 2011 | 257 | 0.050 |
Why?
|
| Postoperative Care | 1 | 2009 | 1486 | 0.050 |
Why?
|
| Algorithms | 2 | 2021 | 13881 | 0.050 |
Why?
|
| Prognosis | 3 | 2018 | 29063 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 13989 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4687 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2005 | 880 | 0.050 |
Why?
|
| Deceleration | 1 | 2020 | 9 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2021 | 387 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6365 | 0.050 |
Why?
|
| Bony Callus | 1 | 2000 | 36 | 0.050 |
Why?
|
| Osteogenesis | 2 | 2005 | 1299 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2011 | 9146 | 0.050 |
Why?
|
| Endoscopes | 2 | 1998 | 175 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2018 | 12720 | 0.050 |
Why?
|
| Acceleration | 1 | 2020 | 181 | 0.040 |
Why?
|
| Atrophy | 1 | 2004 | 1583 | 0.040 |
Why?
|
| Collagen | 2 | 2022 | 2689 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2014 | 21746 | 0.040 |
Why?
|
| Depression | 1 | 2018 | 7766 | 0.040 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 349 | 0.040 |
Why?
|
| Surgical Staplers | 1 | 1998 | 34 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2006 | 1809 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 549 | 0.040 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 25043 | 0.040 |
Why?
|
| Gene Expression | 4 | 2004 | 7799 | 0.040 |
Why?
|
| Registries | 2 | 2023 | 8089 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2021 | 12026 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 558 | 0.040 |
Why?
|
| Fracture Fixation | 1 | 1999 | 354 | 0.040 |
Why?
|
| Biotechnology | 1 | 2018 | 281 | 0.040 |
Why?
|
| Patient Satisfaction | 2 | 2021 | 3396 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2020 | 645 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 1157 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 4042 | 0.030 |
Why?
|
| Tibial Fractures | 1 | 1999 | 269 | 0.030 |
Why?
|
| Surgical Stapling | 1 | 1997 | 97 | 0.030 |
Why?
|
| Platelet-Rich Plasma | 1 | 2018 | 177 | 0.030 |
Why?
|
| Sex Factors | 1 | 2010 | 10397 | 0.030 |
Why?
|
| Suture Techniques | 2 | 2007 | 798 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2020 | 541 | 0.030 |
Why?
|
| Smoking | 1 | 2012 | 8987 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2001 | 1133 | 0.030 |
Why?
|
| Fascia | 1 | 1996 | 135 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2011 | 3309 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2005 | 19229 | 0.030 |
Why?
|
| Mood Disorders | 1 | 2022 | 1106 | 0.030 |
Why?
|
| Regenerative Medicine | 1 | 2018 | 307 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2020 | 2971 | 0.030 |
Why?
|
| Braces | 1 | 2015 | 135 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2018 | 721 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2019 | 1842 | 0.030 |
Why?
|
| Mechanoreceptors | 1 | 1996 | 186 | 0.030 |
Why?
|
| Incidence | 1 | 2012 | 20947 | 0.030 |
Why?
|
| Exercise Test | 1 | 2021 | 2074 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 15540 | 0.030 |
Why?
|
| Polymers | 1 | 2001 | 1621 | 0.030 |
Why?
|
| beta Catenin | 1 | 2018 | 1059 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
| Growth Differentiation Factor 5 | 1 | 2012 | 35 | 0.030 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 3610 | 0.030 |
Why?
|
| Organisms, Genetically Modified | 1 | 2012 | 64 | 0.030 |
Why?
|
| Aggrecans | 1 | 2012 | 90 | 0.030 |
Why?
|
| Bone and Bones | 2 | 2020 | 2575 | 0.030 |
Why?
|
| Drug Approval | 1 | 2019 | 742 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2001 | 1736 | 0.030 |
Why?
|
| Ambystoma mexicanum | 1 | 2012 | 47 | 0.030 |
Why?
|
| Transfection | 1 | 2000 | 5892 | 0.030 |
Why?
|
| Program Development | 1 | 2018 | 1316 | 0.030 |
Why?
|
| Models, Animal | 2 | 2010 | 2171 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 19905 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2019 | 1547 | 0.020 |
Why?
|
| Motivation | 1 | 2021 | 1971 | 0.020 |
Why?
|
| Urodela | 1 | 2010 | 17 | 0.020 |
Why?
|
| New England | 1 | 2014 | 1022 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 1620 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2019 | 1058 | 0.020 |
Why?
|
| Aged | 6 | 2021 | 163280 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 2959 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 1312 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 6622 | 0.020 |
Why?
|
| Placebos | 1 | 2014 | 1676 | 0.020 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2009 | 43 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2019 | 2925 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2022 | 3209 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2016 | 2682 | 0.020 |
Why?
|
| Communication | 1 | 2021 | 3749 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 23338 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2010 | 835 | 0.020 |
Why?
|
| Luciferases | 2 | 1999 | 733 | 0.020 |
Why?
|
| Tensile Strength | 2 | 1998 | 335 | 0.020 |
Why?
|
| Bone Nails | 1 | 2007 | 219 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3674 | 0.020 |
Why?
|
| Risk Factors | 1 | 2012 | 72290 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2006 | 303 | 0.020 |
Why?
|
| Rats | 1 | 2021 | 24260 | 0.020 |
Why?
|
| Proteomics | 1 | 2018 | 3638 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2011 | 2618 | 0.020 |
Why?
|
| Emotions | 1 | 2016 | 2661 | 0.020 |
Why?
|
| Acute Disease | 1 | 2015 | 7149 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 2429 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 1686 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8642 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7913 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 2866 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 11366 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2006 | 644 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 9959 | 0.010 |
Why?
|
| Medial Collateral Ligament, Knee | 1 | 2000 | 25 | 0.010 |
Why?
|
| United States | 1 | 2007 | 69872 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2022 | 41006 | 0.010 |
Why?
|
| Polyesters | 1 | 2001 | 363 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2007 | 2740 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40075 | 0.010 |
Why?
|
| Lac Operon | 1 | 1998 | 238 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2005 | 1951 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2005 | 11483 | 0.010 |
Why?
|
| Tissue and Organ Procurement | 1 | 2006 | 896 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 1678 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 1998 | 334 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1999 | 257 | 0.010 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1998 | 282 | 0.010 |
Why?
|
| Retroviridae | 1 | 1998 | 914 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2018 | 23403 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 1996 | 302 | 0.010 |
Why?
|
| Proprioception | 1 | 1996 | 132 | 0.010 |
Why?
|
| Surgical Instruments | 1 | 1996 | 395 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18029 | 0.010 |
Why?
|
| HIV Infections | 1 | 1995 | 16718 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 57776 | 0.010 |
Why?
|
| Mice | 1 | 1998 | 81183 | 0.000 |
Why?
|